Literature DB >> 23888360

Epidemiology of spondyloarthritis: a review.

Gunnstein Bakland1, Hans C Nossent.   

Abstract

The classification of Spondyloarthritis (SpA) has been revised with the introduction of the ASAS classification criteria. Although this has best been described in ankylosing spondylitis and psoriatic arthritis, there are population studies evaluating the epidemiology of the different subgroups of SpA. In this paper, we present data on the incidence and prevalence of the subgroups of SpA in different populations, and point to data indicating how the introduction of new classification criteria, with the altered perception of the SpA entity, might impact on the epidemiology.

Entities:  

Mesh:

Year:  2013        PMID: 23888360     DOI: 10.1007/s11926-013-0351-1

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  55 in total

1.  The ankylosing spondylopathies.

Authors:  F D Hart
Journal:  Clin Orthop Relat Res       Date:  1971-01       Impact factor: 4.176

2.  Spondyloarthropathies in circumpolar populations of Chukotka (Eskimos and Chukchi): epidemiology and clinical characteristics.

Authors:  S Erdesz; S V Shubin; B P Shoch; N M Mylov; N A Chekalina; L I Benevolenskaya
Journal:  J Rheumatol       Date:  1994-06       Impact factor: 4.666

3.  Ankylosing spondylitis in a Canadian Indian population.

Authors:  J P Gofton; H S Robinson; G E Trueman
Journal:  Ann Rheum Dis       Date:  1966-11       Impact factor: 19.103

4.  Incidence and prevalence of ankylosing spondylitis in Finland.

Authors:  O Kaipiainen-Seppanen; K Aho; M Heliovaara
Journal:  J Rheumatol       Date:  1997-03       Impact factor: 4.666

Review 5.  Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis.

Authors:  Mike J Peters; Irene E van der Horst-Bruinsma; Ben A Dijkmans; Michael T Nurmohamed
Journal:  Semin Arthritis Rheum       Date:  2004-12       Impact factor: 5.532

6.  HLA-B27 Prevalence in Arab Populations and Among Patients with Ankylosing Spondylitis.

Authors:  Khader N Mustafa; Mohammed Hammoudeh; Muhammad Asim Khan
Journal:  J Rheumatol       Date:  2012-07-01       Impact factor: 4.666

7.  Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 arthritis survey.

Authors:  Elina Savolainen; Oili Kaipiainen-Seppänen; Liisa Kröger; Riitta Luosujärvi
Journal:  J Rheumatol       Date:  2003-11       Impact factor: 4.666

8.  Ankylosing spondylitis in Rochester, Minnesota, 1935-1989. Is the epidemiology changing?

Authors:  L D Carbone; C Cooper; C J Michet; E J Atkinson; W M O'Fallon; L J Melton
Journal:  Arthritis Rheum       Date:  1992-12

9.  HL-A 27 and ankylosing spondylitis in B.C. Indians.

Authors:  J P Gofton; A Chalmers; G E Price; C E Reeve
Journal:  J Rheumatol       Date:  1984-10       Impact factor: 4.666

10.  Psoriatic arthritis in Reykjavik, Iceland: prevalence, demographics, and disease course.

Authors:  Thorvardur Jon Love; Bjorn Gudbjornsson; Johann Eli Gudjonsson; Helgi Valdimarsson
Journal:  J Rheumatol       Date:  2007-08-01       Impact factor: 4.666

View more
  19 in total

Review 1.  The role of secukinumab in the treatment of psoriatic arthritis and ankylosing spondylitis.

Authors:  Leticia Garcia-Montoya; Helena Marzo-Ortega
Journal:  Ther Adv Musculoskelet Dis       Date:  2018-09-06       Impact factor: 5.346

Review 2.  [Experiences and results from Rheuma-VOR].

Authors:  A Schwarting; M Dreher; G Assmann; T Witte; K Hoeper; R E Schmidt
Journal:  Z Rheumatol       Date:  2019-10       Impact factor: 1.372

Review 3.  Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries.

Authors:  Márta Péntek; Gyula Poór; Piotr Wiland; Martina Olejárová; Marek Brzosko; Catalin Codreanu; Nóra Brodszky; László Gulácsi
Journal:  Eur J Health Econ       Date:  2014-05-16

Review 4.  [Physical activity, exercise and nutrition in rheumatism : Adjuvant treatment options for inflammatory-rheumatic diseases].

Authors:  M Dreher; M Kosz; A Schwarting
Journal:  Orthopade       Date:  2019-11       Impact factor: 1.087

5.  [How frequent are musculoskeletal diseases in Germany?].

Authors:  A Zink; K Albrecht
Journal:  Z Rheumatol       Date:  2016-05       Impact factor: 1.372

Review 6.  [Dysphagia in cervical spine diseases].

Authors:  R Riepl; T K Hoffmann; E Goldberg-Bockhorn; P Richter; R Reiter
Journal:  HNO       Date:  2019-10       Impact factor: 1.284

7.  Prevalence of axial spondyloarthritis in Poland.

Authors:  Małgorzata Tłustochowicz; Melania Brzozowska; Waldemar Wierzba; Filip Raciborski; Brygida Kwiatkowska; Witold Tłustochowicz; Andrzej Jacyna; Michał Marczak; Bartłomiej Kisiel; Andrzej Śliwczyński
Journal:  Rheumatol Int       Date:  2019-12-04       Impact factor: 2.631

Review 8.  Construct validity of clinical spinal mobility tests in ankylosing spondylitis: a systematic review and meta-analysis.

Authors:  Marcelo P Castro; Simon M Stebbings; Stephan Milosavljevic; Melanie D Bussey
Journal:  Clin Rheumatol       Date:  2015-09-04       Impact factor: 2.980

Review 9.  A meta-analysis for association of TNF-α -308G>A polymorphism with susceptibility to Ankylosing Spondylitis.

Authors:  Masoud Mahdinejad-Yazdi; Mohammad Reza Sobhan; Seyed Alireza Dastgheib; Reza Bahrami; Seyed Hossein Shaker; Hamid Mirjalili; Jalal Sadeghizadeh-Yazdi; Masoud Zare-Shehneh; Hossein Neamatzadeh
Journal:  J Orthop       Date:  2021-07-14

10.  Role of Physical Evaluation in the Early Identification of Axial Spondyloarthritis: A Research Proposal.

Authors:  Marcelo P Castro; Simon M Stebbings; Stephan Milosavljevic; Melanie D Bussey
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2015-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.